Newsroom

Echo Health Ventures invests to build and grow great health care companies.

Find out more about how Echo Health Ventures and its portfolio companies are transforming health care.

All News

Gormley’s Take: Medical Investors Zig as Health Law Overhaul Zags

Press
In an uncertain political environment, medical venture capitalists are interested in technologies that could weather policy shifts, with the assumption that certain trends are here to stay- like efforts to lower costs, put patients in charge of their care, and fight rising drug prices.
Medical Equipment

Digital Health Is Dead, Says This Health-Tech Investor

Press
There’s no argument that our health care system demands fixing. However, Digital Health entrepreneurs have learned some expensive lessons in recent years. Given the benefit of these lessons- outlined in this article, with some suggested adjustments for the future- we now need to rededicate ourselves to the fundamentals of building great, lasting companies in our unique industry.

Data-Crunching Technology Spurs Insurance Dollars

Press
Cambia Health Solutions has launched a pilot program with GNS Healthcare, leveraging the data-analysis capabilities that GNS offers to help in forecasting emerging illnesses and deploying resources. The goal is to better manage chronic diseases and improve the overall health of their members.
Balloons

Circulation Secures $10.5 Million in Funding

News Release
Echo Health Ventures has participated in Series A financing for Circulation, a Boston, Massachusetts-based company specializing in non-emergency medical transportation (NEMT). Circulation is a new way to book NEMT services with the benefit of HIPAA compliance; it can seamlessly be integrated with healthcare systems as well as both established and on-demand vendors. CEO Robin Heffernan states that Circulation can significantly increase patient satisfaction rates while simultaneously cutting ride costs by up to 70 percent.
Pharmacy

Health-Care VCs Take Aim at High Drug Prices

Press
As reported in the Wall Street Journal Pro, while "Consumers view high drug prices with outrage, venture capitalists see them as an opportunity". Startups are working to make costs more manageable, bring more transparency to drug pricing, and provide patient tools to ensure that medications are used effectively. This innovative thinking garners attention from investors. “The innovation economy [has] to play a big role in addressing the challenge,” according to Rob Coppedge, CEO of Echo Health Ventures.
Health Care

With $5.6M in New Funding, Upfront Healthcare Services Wants to Streamline Your Doctor Visits

News Release
Upfront Healthcare Services, a Chicago healthtech startup that helps physician practices get smarter about their scheduling, announced Thursday that it has raised a $5.6 million Series A round of funding to support growth and accelerate its product development cycle. Nashville Capital Network led the round, in which Echo Health Ventures, Hyde Park Venture Partners and Martin Venture participated. Upfront uses data science to analyze visits at large physician practices to understand how scheduling and logistics can be improved to make the practice more effective and profitable.

Echo Health Ventures’ Rob Coppedge Shares What’s Next in Health Care Investment

Press
This month Echo Health Ventures CEO Rob Coppedge presented to the Harvard Business School Healthcare Alumni Association about the latest happenings in the health care venture funding market, and what strategic investors can offer companies looking to make health care better for people. Rob shared his view on digital health (that it’s dead), on health care (it’s very complicated for entrepreneurs), and offered his perspective on the opportunities that lie ahead for entrepreneurs and strategic investors. He also offered insight into the challenges entrepreneurs face when working with large health plans, and shared the state of health care venture moving into 2018 (hint: AI, behavioral health and HSA play big).